Dr. Richard Vickers
Richard Vickers joined Summit Therapeutics company in 2003 and has served as their Chief Scientific Officer, Antimicrobials, since October 2013. During his time at the Summit Therapeutics company, Dr. Vickers has worked in a variety of roles involved in the development and management of various antibacterial therapeutic programs, including our antibiotic program for the treatment of CDI. Prior to joining Summit, Dr. Vickers undertook postdoctoral research studies with Professor Stephen Davies at the University of Oxford and held a Stipendiary Lectureship in organic chemistry at St. Catherine's College in Oxford.
Dr. Vickers received a Ph.D. in organic chemistry from the University of Reading and a B.Sc. in chemistry from King's College London.